Current Prices from Liminatus Pharma, Inc. - Class A Common Stock

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	LIMN	USD	31.07.2025 22:15	6,30 USD	-0,59 USD -8,56 %

Performance

Day	Week	Month	3 Months	6 Months	1 Year	5 Years
-10,00 %	-28,81 %	-46,50 %	9,00 %	-65,52 %	-65,52 %	-65,52 %

Company Profile for Liminatus Pharma, Inc. - Class A Common Stock Share

Liminatus Pharma, Inc. operates as a clinical-stage immuno-oncology company that develops novel cancer therapies. The company is based in LA Palma, California.

Company Data

Name Liminatus Pharma, Inc. - Class A Common Stock

Company Liminatus Pharma, Inc. Class A Common Stock

Symbol LIMN

Website https://liminatuspharma.com

Primary Exchange

NASDAQ

ISIN US53271X1081

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Mr. Chris Kim J.D., L.L.M.

Market Capitalization 154 Mio

Country United States of America

Currency USD

Employees 0,0 T

Address 6 Centerpointe Drive, La Palma

IPO Date 2025-05-01

Ticker Symbols

Name	Symbol
NASDAQ	LIMN

More Shares

Investors who hold Liminatus Pharma, Inc. - Class A Common Stock also have the following shares in their portfolio:

SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) 7.0922% /FLTG RTE CAP CONTR NTS Bond

VIRPAX PHARMACEUTICALS INC Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog